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Abstract: 
 
Therapeutic agents used in the treatment of cancer are known to develop resistance against 
cancer cells. Hence, there is a continuing need to investigate novel agents for the treatment and 
management of cancer. Antitumor activity of greensporone C (GC), a new resorcylic acid 
lactone isolated from an organic extract of a culture of a Halenospora sp. freshwater fungus, was 
subjected for screening against a panel of leukemic cell lines (K562, U937, and AR320). In all 
the three cell lines, cell proliferation was inhibited in dose-dependent fashion. GC further 
arrested the cells in SubG0 phase in dose-dependent manner. Annexin V/PI dual staining data 
confirmed apoptotic death of treated K562 and U937 leukemic cells. Treatment with GC 
suppressed constitutively phosphorylated AKT and downregulated expression of inhibitor of 
apoptotic proteins XIAP, cIAP-1, and cIAP-2. In summation to this, GC-treated leukemic cells 
upregulated protein expression of pro-apoptotic proteins, Bax with concomitant decrease in 
expression of anti-apoptotic proteins including Bcl-2 and Bcl-xL. Upregulation of Bax was 
associated with cytochrome c release which was confirmed from the collapse of mitochondrial 
membrane. Released cytochrome c further activated caspase cascade which in turn initiated 
apoptosis process. Anticancer activity of this isolated fungal compound GC was potentiated via 
stimulating production of reactive oxygen species (ROS) along with depletion of reduced 
glutathione (GSH) levels in K562 and U937 leukemic cells. Pretreatment of these cells with N-
acetyl cysteine prevented GC-induced depletion of reduced GSH level and mitochondrial-
caspase-induced apoptosis. Altogether, our data show that GC modulates the apoptotic response 
of human leukemic cells and raises the possibility of its use as a novel therapeutic strategy for 
hematological malignancies. 
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Therapeutic agents used in the treatment of cancer are known to develop resistance
against cancer cells. Hence, there is a continuing need to investigate novel agents
for the treatment and management of cancer. Antitumor activity of greensporone C
(GC), a new resorcylic acid lactone isolated from an organic extract of a culture
of a Halenospora sp. freshwater fungus, was subjected for screening against a
panel of leukemic cell lines (K562, U937, and AR320). In all the three cell lines,
cell proliferation was inhibited in dose-dependent fashion. GC further arrested the
cells in SubG0 phase in dose-dependent manner. Annexin V/PI dual staining data
confirmed apoptotic death of treated K562 and U937 leukemic cells. Treatment with
GC suppressed constitutively phosphorylated AKT and downregulated expression of
inhibitor of apoptotic proteins XIAP, cIAP-1, and cIAP-2. In summation to this, GC-
treated leukemic cells upregulated protein expression of pro-apoptotic proteins, Bax
with concomitant decrease in expression of anti-apoptotic proteins including Bcl-2
and Bcl-xL. Upregulation of Bax was associated with cytochrome c release which
was confirmed from the collapse of mitochondrial membrane. Released cytochrome c
further activated caspase cascade which in turn initiated apoptosis process. Anticancer
activity of this isolated fungal compound GC was potentiated via stimulating production
of reactive oxygen species (ROS) along with depletion of reduced glutathione (GSH)
levels in K562 and U937 leukemic cells. Pretreatment of these cells with N-acetyl
cysteine prevented GC-induced depletion of reduced GSH level and mitochondrial-
caspase-induced apoptosis. Altogether, our data show that GC modulates the apoptotic
response of human leukemic cells and raises the possibility of its use as a novel
therapeutic strategy for hematological malignancies.
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INTRODUCTION
Natural products are and have been playing vital role in
the area of drug discovery. In the last ∼75 years, out of
175 new entities that were labeled as anti-cancer 49% were
isolated from natural products (Newman and Cragg, 2016).
Plantae, eubacteria, and fungi are the major kingdoms of
life to provide secondary metabolites. From approximately
0.5 million secondary metabolites (natural products) that have
been described to date, about 14% (70,000) were of microbial
origin. Moreover, of about 33,500 bioactive microbial natural
compounds, 47% were of fungal origin (Bills and Gloer, 2016).
Fungal secondary metabolites have contributed immensely to the
drug discovery process by providing many novel drugs, including
β-lactam antibiotics (penicillin G), cholesterol-lowering agents
(lovastatin), and immunosuppressant (fingolimod) (Fleming,
1946; Vagelos, 1991; Strader et al., 2011). Recently, fungal
compounds have been gaining a lot of importance and
recognition in the area of anti-cancer drug discovery world-
wide with some being currently under investigation in different
phases of clinical trials (Kinghorn et al., 2016). From estimated
5.1 million species of fungi on earth (Blackwell, 2011), only
about 99,000 species have been described (Blackwell, 2011),
and a smaller fraction of these were explored for bioactive
secondary metabolites (Kinghorn et al., 2016). Freshwater fungi,
which flourishes in freshwater ecosystems and is primarily
involved in the decomposition of submerged plant debris
represents an even less studied area in mycology with only
about 3,000 species being identified so far (Jones et al.,
2014).
As part of our research to explore the chemical diversity
of freshwater fungi, a series of 14 resorcylic acid lactones
were isolated and identified from an organic fraction of a
freshwater fungal isolate Halenospora sp. Among the isolated
compounds, greensporone C (GC) showed promising cytotoxic
activity when examined against the MDA-MB-435 (breast
cancer) and HT-29 (colon) cancer cell lines, with IC50 values
of 2.9 and 7.5 µM, respectively (El-Elimat et al., 2014).
Macrocyclic compounds due to their vivid pharmacological
activities and better bioavailability have gained growing interest
in the area of drug discovery (Giordanetto and Kihlberg,
2014).
Our study aimed to understand the mechanism of GC-
mediated cytotoxic effects using a series of leukemic cells as
model. GC-treated K562 and U937 cells underwent apoptosis
which was mediated by inhibition of uncontrolled cell growth
by downregulating protein expression of constitutively activated
AKT. Inhibitor of apoptosis proteins (IAPs) known to be
downstream targets of AKT along with various antiapoptotic
proteins such as Bcl-2, Bcl-xL, etc. were also downregulated
favoring mitochondrial-caspase-mediated apoptosis. In addition,
GC-mediated cytotoxic effects are mediated by generation
of ROS. Our findings strongly suggest that GC has a
strong potential to become a promising lead compound
in the treatment of leukemic cells and in other human
cancers where PI3-kinase/AKT pathways are constitutively
activated.
MATERIALS AND METHODS
Isolation of Greensporone C (GC) From
Aquatic Fungi
Greensporone C was isolated from a chloroform:methanol (1:1)
extract of a culture of an aquatic fungus (G87) that was samples
from a submerged woody substrate collected from a stream on
the campus of the University of North Carolina at Greensboro.
The organic extract was further subjected to liquid–liquid
partitioning and then to a series of fractionation and purifications
procedures, including normal-phase flash chromatography and
reversed-phase preparative and semi-preparative HPLC. The
structure of GS was identified using various spectroscopic and
spectrometric techniques, including HRESIMS, 1D-NMR (1H
and 13C), and 2D-NMR (COSY, edited-HSQC, and HMBC).
The absolute configuration of the stereogenic center (C-2)
was established as 2S. The purity of GC was measured using
UPLC and found to be >98% (Figure 1A; El-Elimat et al.,
2014).
Chemicals and Reagents
Antibodies viz., caspase-9, caspase-8, caspase-3, cleaved-caspase-
3, poly(ADP-ribose) polymerase (PARP), XIAP, cIAP-1, cIAP-
2, Bcl-2, Bcl-xL, and Bax were procured from Cell Signaling
Technologies (Beverly, MA, United States) and GAPDH antibody
was purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA, United States). Annexin V-FITC, propidium iodide
staining solution, Hoechst 33342 Solution, BD Cytofix/Cytoperm
plus fixation and permeabilization solution kit, and BD
MitoScreen (JC-1) Kit were purchased from BD Biosciences (NJ,
United States). CCK-8 kit and N-acetyl cysteine (NAC) was
obtained from Sigma-Aldrich (St. Louis, MO, United States).
z-VAD-FMK was purchased from Calbiochem (San Diego, CA,
United States). CellROX Green, MitoSOX Red, and ThiolTracker
Violet were purchased from Invitrogen (MA, United States).
Cell Culture
The leukemic cells K562, U937, and AR230 were grown as
described previously (Iskandarani et al., 2016) in RPMI 1640
medium supplemented with 10% fetal bovine serum (FBS),
100 U/ml penicillin, and 100 U/ml streptomycin at 37◦C in a
humidified atmosphere containing 5% CO2. Peripheral blood
mononuclear cell (PBMC) was obtained from healthy donors
after informed consent and with ethical approval (Study number:
16062/16) from the Institutional Review Board, Hamad Medical
Corporation, Doha, Qatar. PBMCs were separated with Ficoll-
Paque-based density centrifugation and then cultured in RPMI
1640 medium supplemented with 10% FBS, 100 U/ml penicillin,
and 100 U/ml streptomycin at 37◦C in a humidified atmosphere
containing 5% CO2.
Cell Proliferation Assay
The panel of leukemic cell lines treated in presence and absence
GC was subjected for evaluating cell viability by using CCK-8
colorimetric method. The amount of formazan dye formed
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FIGURE 1 | Effects of GC on cell proliferation and cell cycle. (A) Chemical structure of GC. (B) Inhibition of cell viability was measured using MTT assay as described
under the section “Materials and Methods.” Cell cycle fraction analysis of cells in response to GC. K562 (C) and U937 (D) cells were treated with GC as indicated
and analyzed by flow cytometry. GC significantly enhanced SubG0 fraction in K562 (E) and U937 (F). The graph displays the mean ±SD of three independent of
experiments. ∗P < 0.05.
by reduction of WST-8 salt [2-(2-methoxy-4-nitrophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium] by
dehydrogenase present in cells is directly related to the presence
of viable cells. In brief, 1 × 104 cells per well were plated in
96-well microtiter plates and treated with indicated doses of GC
for 24 h. At the end of 24 h, as per manufacturer protocol CCK-8
solution was added and plates were read at 450 nm. Percentage of
cell viability was calculated as OD of the experiment samples/OD
of the control sample× 100 (Wang et al., 2018).
Cell Cycle Analysis
K562 and U937 were treated with escalating concentrations of
GC for 24 h. Cell cycle analysis was performed using Hoechst
33342 and cell cycle fractions were analyzed by flow cytometry
BD LSRFortessa analyzer (BD Biosciences, NJ, United States)
(Siveen et al., 2014).
Annexin V/Propidium Iodide Dual
Staining
K562 and U937 cells were treated with various doses of GC as
indicated for 24 h. Cells were washed with PBS and stained with
fluorescein-conjugated annexin-V and propidium iodide in 1×
annexin binding buffer for 20 min. Flow cytometry was used to
quantify cells that were either viable or had undergone apoptosis
or necrosis after treatment (Badmus et al., 2015). Percentage
apoptosis was expressed as a combination of cells present in early
and late apoptosis (Prabhu et al., 2017).
Cell Lysis and Immunoblotting
Lysates of GC-treated leukemic cells were prepared using
2× Laemmli buffer as mentioned earlier (Uddin et al.,
2004). For protein quantification ND-1000 (NanoDrop
Technologies, Thermo Scientific, United States) was used.
After adding reducing agent cell lysates were resolved using
SDS–PAGE and transferred to polyvinylidene difluoride (PVDF)
membrane (Immobilon, Millipore, Billerica, MA, United States).
Membranes were then probed with various antibodies as
described previously (Uddin et al., 2004). Development and
visualization of blots were done using ChemiDoc System
(Amersham, Bio-Rad, United States).
Measurement of Mitochondrial
Membrane Potential
K562 and U937 cells were treated with different concentrations
of GC for 24 h. Cells were stained with JC-1 and mitochondrial
membrane potential was measured by flow cytometry using a
BD LSRFortessa analyzer (BD Biosciences, NJ, United States)
(Iskandarani et al., 2016).
Assay for Release of Cytochrome c
K562 and U937 cells were treated with and without GC
and resuspended in hypotonic buffer after harvesting by
centrifugation. Cytosolic and mitochondrial protein fractions
were isolated by using protocol as described earlier (Uddin et al.,
2005). Cytosolic fraction of K562 and U937 was resolved using
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12% SDS–PAGE and immunoblotted with anti-cytochrome c and
GAPDH (Uddin et al., 2005).
Measurement of Mitochondrial
Superoxide
K562 and U937 cell lines were treated with increasing
concentrations of GC for 24 h. Cells were harvested and
washed with HBSS. Cells were stained with 5 µM MitoSOX
Red Mitochondrial Superoxide Indicator (Invitrogen, MA,
United States) in HBSS for 20 min at 37◦C and analyzed by
flow cytometry (Ex: 488, Em: 575/26) to quantify the levels of
mitochondrial superoxide (Syn et al., 2017).
Measurement of Reactive Oxygen
Species
K562 and U937 were treated with increasing doses of GC for
24 h, and washed with HBSS after harvesting. The cells were
stained with 5 µM CellROXTM Green Reagent (Invitrogen, MA,
United States) in HBSS for 30 min at 37◦C, washed twice and
analyzed by flow cytometry (Ex: 488, Em: 530/30) to quantify the
levels of ROS (Weidner et al., 2016).
Measurement of Reduced Glutathione
Cells were treated with GC, harvested, and washed with HBSS.
The cells were then stained with 10 µM ThiolTrackerTM Violet
(Invitrogen, MA, United States) in HBSS for 30 min at 37◦C.
Cells were washed twice and analyzed by flow cytometry (Ex: 405,
Em: 525/50) to quantify the levels of reduced glutathione (GSH)
(Morzadec et al., 2014).
Statistical Analysis
Data are expressed as the mean ± standard deviation (SD).
Paired student’s t-test was used for statistical comparisons
between various experimental groups. GraphPad Prism (version
7.0 for Windows, GraphPad Software Inc., San Diego, CA,
United States1) was used for all statistical analysis and for figure
generation. Values of ∗P ≤ 0.05 and ∗∗P ≤ 0.001 reflected to be
statistically significant.
RESULTS
Isolation and Characterization of GC
From Aquatic Fungus
Greensporone C (GC) was isolated as a colorless compound from
organic fraction as mentioned above. Using HRESIMS, molecular
formula for GC was assigned as C19H25O with molecular weight
of 319.15. Purity of isolated compound was established using
UPLC and was found to be >98% (El-Elimat et al., 2014).
GC Inhibits Cell Proliferation and Induces
Apoptosis in Leukemia Cell Lines
Initially we sought to determine the effect of GC on panel of
leukemic cell lines (K562, U937, and AR230). Cells were treated
1http://www.graphpad.com
with increasing concentrations of GC for 24 h and MTT assay
was performed to assess the viability. As shown in Figure 1B,
5, 10, 25, and 50 µM of GC resulted in significant reduction
of cell viability in all the cell lines. At a dose of 50 µM, 10.0,
4.0, and 17.0% of cells were found to be viable in K562, U937,
and AR230 cells, respectively, in comparison to control. GC did
not show any effects on normal peripheral mononuclear cells
(PBMC) (Supplementary Figure 1A). In subsequent experiments,
cell cycle phase distribution analysis was performed using flow
cytometry. As depicted in Figures 1C–F, the increase in subG0
population in GS-treated cells was accompanied with a decrease
percentage of the cells in G0/G1, S, and G2/M phases compared
to control, a feature of cells that undergo apoptosis (Healy
et al., 1998; Huang et al., 2015). Annexin V/PI dual staining was
further employed to confirm that GC-induced subG0 apoptotic
fraction is indeed an apoptotic feature (Figures 2A–D). We next
investigated the functional role of GC on caspase activation in
leukemic cells. Western blot analysis revealed that GC treatment
of leukemic cell activates caspase-9, and caspase-3 in a dose-
dependent manner. Consistent with this cleavage of PARP
was also increased with the increase in GC concentrations.
An increase in γ-H2AX-a marker for DNA double-stranded
breakage was observed in response to GC treatment in leukemic
cells suggesting a role of DNA damage in GC-mediated apoptosis
(Figures 2E,F). Moreover, GC-mediated caspase-3 activation and
PARP cleavage were reversed in leukemic cells pretreated with
20 µmol/l z-VAD-FMK, a pan caspase inhibitor (Figures 2G,H),
demonstrating that the apoptosis triggered by GC was caspase
dependent (Prabhu et al., 2017). In addition we also performed
a combination study with imatinib, a well-known anticancer
agent to determine whether GC can potentiate the apoptotic
effects of imatinib in leukemic cells. K562 cells were treated
with subtoxic doses of GC (10 µM) and imatinib (1 µM) for
24 h. As shown in Supplementary Figure, GC treatment of K562
potentiated imatinib-induced apoptotic effects (Supplementary
Figures 1B,C).
GC Treatment of Leukemia Cells Causes
Suppression of Constitutive AKT and Its
Associated Signaling Pathways
Previous reports have shown link between deregulated PI3-
kinase/AKT signaling pathways and sustained survival of cells
in hematological malignancy (Hussain et al., 2011, 2017).
Furthermore, it has been shown that aberrant activation of AKT
leads to oncogenic affects via activation of protein kinases and
overexpression of antiapoptotic proteins (Rivera Rivera et al.,
2016). We therefore, next determined the effect of GC on
constitutively activated AKT. As shown in Figures 3A,B that
GC treatment of leukemic cells resulted in dephosphorylation of
AKT at Ser473 in a dose-dependent manner without affecting
AKT protein levels. These findings support the notion that
GC-mediated inhibition of cell viability is mediated through
inactivation of AKT signaling pathway.
In the past few years IAP family members have been gaining
importance in cancer treatment due to their ability to overexpress
themselves in comparison to other deregulated proteins. High
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FIGURE 2 | Greensporone C induces apoptosis in leukemic cells. K562 (A) and U937 (B) cells were treated with GC as indicated and analyzed by flow cytometry.
GC significantly induced apoptosis in dose-dependent manner in K562 (C) and U937 (D). The graph displays the mean ± SD of three independent of experiments.
∗P < 0.05 and ∗∗P < 0.001. GC−mediated activation of the caspase cascades in K562 (E) and U937 (F) cells. z-VAD-FMK reversed GC-induced caspase
activation in K562 (G) and U937 (H) cells. Cells were treated with GC and z-VAD-FMK alone and in combination for 24 h. At the end of 24 h they were lysed and
immunoblotted with antibodies against caspase-9, caspase-3, cleaved caspase-3, PARP, and GAPDH.
FIGURE 3 | Greensporone C dephosphoryalted AKT and suppresses the expression of downstream targets. K562 (A) and U937 (B) cells were treated with
increasing doses of GC for 24 h as indicated. After cell lysis, equal amounts of proteins were separated by SDS–PAGE, transfered to PVDF membrane, and
immunoblotted with antibodies of p-AKT, AKT, XIAP, c-IAP1, c-IAP2, and GAPDH as indicated.
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FIGURE 4 | Greensporone C-induced mitochondrial signaling pathways in leukemic cells. GC treatment causes alteration in Bcl-2 expression. K562 (A) and U937
(B) cells were treated with increasing doses of GC for 24 h as indicated. After cell lysis, equal amounts of proteins were separated by SDS–PAGE, transfered to
PVDF membrane, and immunoblotted with antibodies against caspase-8, cleaved caspase-8, Bid, and GAPDH as indicated. K562 (C) and U937 (D) cells were
treated with GC as indicated and expression level of Bax and Bcl-2 was determined by immunoblotting with antibodies against Bax, Bcl-2, and GAPDH. Data
obtained from immunoblot analyses of Bax and Bcl-2 in leukemic cell lines were used to evaluate the effects of GC on Bax/Bcl-2 ratio. Densitometric analysis of Bax
and Bcl-2 bands in K562 (E) and U937 (F) cells was performed using AlphaImager Software (San Leandro, CA, United States), and data (relative density normalized
to GAPDH) were plotted as Bax/Bcl-2 ratio. GC treatment causes the loss of mitochondrial membrane potential in leukemic cells. K562 (G) and U937 (H) cells were
treated with indicated doses of GC for 24 h. After JC1 staining cells were analyzed by flow cytometry as described in the section “Materials and Methods.” The
graph displays the mean ± SD of three independent of experiments. ∗P < 0.05 and ∗∗P < 0.001. GC-induced release of cytochrome c. K562 (I) and U937 (J) cells
were treated with and without GC for 24 h. Cytoplasmic fraction was isolated as described in the section “Materials and Methods.” Cell extracts were separated on
SDS–PAGE, transferred to PVDF membrane, and immunoblotted with an antibody against cytochrome c and GAPDH.
levels of IAPs promote survival of cancerous cells by suppressing
apoptotic process (Hassan et al., 2014; Rathore et al., 2017).
Accumulated evidences have indicated existence of correlation
between AKT and XIAP. Phosphorylation of XIAP by AKT
inhibits autoubiquitination and degradation process of XIAP
thereby preventing apoptosis induced by caspase activation
and conferring resistance to chemotherapeutic agents (Dan
et al., 2004). Moreover, IAP family members have been found
to be upregulated in cells when a constitutively active AKT
is transfected into the cell (Jo et al., 2017) suggesting the
link between AKT and IAP proteins. Therefore, we sought to
determine whether GC-mediated suppression of AKT activity
affects the expression of IAPs family members. Our results
confirmed the ability of GC in suppressing expression of XIAP,
cIAP-1, and cIAP-2 in both the cell lines. Altogether, western
blot analysis conclude about involvement of IAP proteins in
GC-mediated apoptosis.
GC Treatment Suppresses Bcl-2
Expression and Enhances Bax/Bcl-2
Ratio in Leukemic Cells
The apoptotic signaling is initiated by activation of caspase-8 that
leads to activation of Bid and its translocation to mitochondrial
membrane for its pro-apoptotic functions (Uddin et al., 2008). As
shown in Figures 4A,B, treatment of K562 and U937 cells with
GC resulted in activation of caspase 8 with subsequent decreased
level of bid, a notion for its truncation. The truncated Bid is
involved in regulation of Bax, a member Bcl-2 family (Anto et al.,
2002). Bcl-2 family members play a significant and pivotal role
in regulating apoptosis by maintaining a balance between anti-
apoptotic molecules such as Bcl-2 and pro-apoptotic molecule
Bax. Slight imbalance or disturbance in their levels leads to
induction or inhibition of cell death (Martinou and Youle, 2011).
Therefore, the effect of GC treatment on the expression levels
of Bax and Bcl-2 in the leukemic cell lines was evaluated. As
shown in Figures 4C,D treatment of leukemic cells with GC
caused a decrease in expression levels of anti-apoptotic Bcl2
protein with subsequent increase in expression level of pro-
apoptotic protein Bax. Raisova et al. (2001) reported that low
Bax/Bcl-2 ratio is associated with resistant cells whereas high
Bax/Bcl-2 ratio is considered as characteristic feature for sensitive
cells that may undergo apoptosis on drug treatment. In our
study, the densitometric analysis revealed an increase in the
Bax/Bcl-2 ratio in both cell lines (Figures 4E,F). These results
are in concordance with findings of Raisova et al. (2001) and
others (Thomas et al., 1996; Pepper et al., 1997; Raisova et al.,
2001).
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FIGURE 5 | GC increases ROS generation in leukemic cells. K562 (A,C) and U937 (B,D) were treated with GC for 24 h. Cellrox and mitoSOX assays were
performed to determine the level of ROS by flow cytometry as described in the section “Materials and Methods.” The graph displays the mean ± SD (standard
deviation) fold change release of ROS of three experiments. P < 0.05, ∗∗P < 0.001. Effect of NAC on GC-induced generation of ROS. K562 (E,G) and U937 (F,H)
were pre-treated with 10 mM NAC, subsequently treated with 25 µM GC for 24 h. Cellrox and mitoSOX assays were performed as described in the section
“Materials and Methods.” The graph displays the mean ± SD fold change release of ROS of three experiments. P < 0.05, ∗∗P < 0.001. Effect of GC on GSH levels
in leukemic cell lines. K562 (I) and U937(J) cells were treated with GC for 24 h and GSH level was determined by using ThioTracker assay kit and level of GSH level
determined by flow cytometry. NAC pre-treated pre-ALL cell prevented GC-induced depletion of GSH in K562 (K) and U937 (L) cells. K562 and U937 cells were
pretreated with 10 mM NAC, subsequently treated with 25 µM GC as indicated for 24 h and GSH content was determined by ThioTracker assay kit and level of GSH
level determined by flow cytometry. The graph represents mean ± SD, ∗P < 0.05, ∗∗P < 0.001.
GC-Mediated Activation of Mitochondrial
Apoptotic Pathways in Leukemic Cells
The effect of GC on mitochondrial membrane potential was
examined using JC1 stain. K562 and U937 cells were treated with
10, 25, and 50 µM GC for 24 h. Treatment of leukemic cells
with GC resulted in loss of mitochondrial membrane potential as
measured by JC1-stained green fluorescence, depicting apoptotic
cells (Figures 4G,H additional images representing loss in
mitochondrial membrane potential are shown in Supplementary
Figures 2A,B). It has been shown that loss of mitochondrial
membrane potential can induce the release of cytochrome c from
mitochondria to the cytosol during the apoptosis (Cai et al.,
2001; Looi et al., 2013). We sought to determine whether GC
treatment of leukemic cells could cause the release of cytochrome
c from mitochondria to cytosol in K562 and U937. As shown in
Figures 4I,J, treatment of K562 and U937 cells by GC-resulted
cytochrome c expression was markedly increased as visualized
and analyzed by western blot analysis. An increase in the band
intensity of cytochrome c in cytosolic fraction suggests that
GC treatment of leukemic cells causes apoptosis via intrinsic
apoptotic pathway (Chandra et al., 2002).
GC-Mediated Generation of ROS in
Leukemic Cells
Chemotherapeutic compounds play an important role through
generation of ROS which subsequently causes apoptosis in
various cancer cells (Bhattacharyya et al., 2014; Gundala et al.,
2014; Panda et al., 2014). ROS are highly reactive molecules
which play important role in the maintenance and regulation of
normal cell proliferation and differentiation. However, increase
in levels of ROS is directly related to increased DNA damage
and increased protein levels that causes cells to undergo
apoptosis (Zhou et al., 2014). Besides this, attack on membrane
phospholipids along with a loss in mitochondrial membrane
potential occurs when an excess amount of ROS are produced
in mitochondria, which ultimately releases apoptosis-inducing
factors followed by caspase cascade activation and nuclear
condensation (Lee et al., 2014; Liang et al., 2016). Generation of
ROS is regarded as a prime factor for mitochondrial-dependent
apoptosis. In line of these findings we investigated the role
of GC in inducing ROS at the cellular level using Cell ROX
assay by flow cytometry. K562 and U937 cells were treated
with increasing doses of GC for 24 h. GC-treated leukemic
cells resulted increase levels of ROS at the cellular level. The
rise in intracellular levels of ROS is directly proportional to
the amount of damage caused to the cellular components
including mitochondria (Trachootham et al., 2009; Hamanaka
and Chandel, 2010; Wellen and Thompson, 2010). Thus, we
next thought to explore ROS-induced mitochondrial dysfunction
using an oxidant-sensitive fluorescent dye, Mito-SOX red.
Increase in the intensity levels of red fluorescence in MitoSOX
assay corresponds to increasing O−2 levels in leukemic-treated
cells (Maharjan et al., 2014). Figures 5A–D depict increased
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FIGURE 6 | GC-mediated generation of ROS causes apoptosis in leukemic cells. NAC pre-treated leukemic cells prevented GC-induced increase in sub-G0 fraction
in K562 (A) and U937 (B) cells. K562 and U937 cells were pretreated with 10 mM NAC, subsequently treated with 25 µM GC as indicated for 24 h, and cell cycle
fraction was measured by flow cytometry. The graph displays the mean ± SD of three independent of experiments. ∗P < 0.05 and ∗∗P < 0.001. NAC pre-treated
leukemic cell prevented GC-induced apoptosis. K562 (C) and U937 (D) cells were pretreated with 10 mM NAC, subsequently treated with 25 µM GC as indicated
for 24 h and apoptosis was measured by staining with fluorescein-conjugated annexin-V and propidium iodide (PI) and analyzed by flow cytometry. The graph
displays the mean ± SD of three independent of experiments. ∗P < 0.05 and ∗∗P < 0.001. NAC pre-treated leukemic cells prevented GC-mediated loss of
mitochondrial membrane potential. K562 (E) and U937 (F) cells were pretreated with 10 mM NAC, subsequently treated with 25 µM GC as indicated for 24 h and
loss of mitochondrial membrane potential was measured by JC1 staining and flow cytometry. The graph displays the mean ± SD of three independent of
experiments. ∗P < 0.05 and ∗∗P < 0.001. NAC pre-treated leukemic cells prevented GC-mediated activation of caspases. K562 (G) and U937 (H) cells were
pretreated with 10 mM NAC, subsequently treated with 25 µM GC as indicated for 24 h and lysed cell extracts were separated on SDS–PAGE, transferred to PVDF
membrane, and immunoblotted with an antibody against procaspase-3, cleaved caspase-3, PARP, and tubulin.
levels of ROS in leukemic cells as confirmed by cellROX and
mitoSOX assay (Lee et al., 2017). Overall, the data showed
that the role of GS in inducing ROS generation at cellular
and mitochondrial levels was accompanied by apoptosis. NAC
possesses the ability to inhibit oxidative stress by scavenging
ROS directly. In the next experiment K562 and U937 cells
were pretreated with NAC for 1 h followed by 25 µM GC.
NAC abolished ROS generated by GC in both cell lines
(Figures 5E–H). The cellRox and MitoSox data were in accord
with each other.
Effect of GC on Glutathione Level in
Leukemic Cell Lines
Normal cells have the competence to detoxify themselves
from various damaging oxidizing agents by possessing
antioxidant enzyme and nonenzymatic antioxidants. One
such antioxidant is GSH, which possesses multi-facet functions
like cell differentiation, proliferation, and apoptosis. Imbalance
in GSH levels is reported in many diseases including cancer.
Substantial evidences available indicates increased GSH levels
confer to chemo-resistance in tumor cells whereas decreased
levels can sensitize cells toward cell death (Traverso et al., 2013).
We, therefore, evaluated whether GC treatment of K562 and
U937 cells reduced GSH level in leukemic cells. GC-treated
leukemic cells exhibited significant depletion of GSH in a
dose-dependent manner. NAC is one of the most commonly
used synthetic precursors of cysteine and GSH and scavenges
free radical via increasing GSH levels thereby attributing to its
anti-ROS activity (Halasi et al., 2013). Pretreatment of leukemic
cells with NAC followed by GC treatment significantly reversed
GC-induced depletion of GSH level in K562 and U937 cells
(Figures 5I–L).
GC-Mediated ROS Generation Involved
in Apoptotic Cell Death in Leukemic
Cells
Our experimental data provided insight into GC-induced
apoptosis through ROS generation, we sought to determine
whether ROS is involved in GC-induced leukemic cell death.
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As shown in Figures 6A–F (additional images are shown as
Supplementary Figures 3A–F), treatment of K562 and U937 cell
with GC significantly induced level SubG0 fraction of cell cycle,
annexin V/PI staining, and loss of mitochondrial membrane
potential in leukemic cell lines whereas pretreatment with 10 mM
NAC markedly abrogated the GC-induced effects. Furthermore,
NAC pretreatment of leukemic cells also prevented GC-induced
activation of caspases and PARP cleavage (Figures 6G,H). This
observation strongly implicates that GC-induced apoptosis in
leukemic cells is mediated by generation of ROS.
DISCUSSION
Natural products have been gaining recognition and are
becoming a significant part of research in the area of drug
development and discovery. Natural products continue to offer
a diverse source of bioactive compounds for drug discovery
(Kingston, 2011; Newman and Cragg, 2016). Greensporone C
(GC) is a resorcylic acid lactones that was isolated from a
freshwater aquatic fungus Halenospora sp. (El-Elimat et al., 2014).
We have previously shown that GC suppressed growth of MDA-
MB-435 and HT-29 cells (El-Elimat et al., 2014). However, the
antiproliferative effects GC and its underlying mechanism on
leukemic cells have not been reported. In this study our results
showed that GC induced a dose-dependent cytotoxic effects in
leukemic cell lines. Our findings indicated that the inhibitory
effect of GC on the growth of leukemic cells might be contributed
by the induction of cell cycle arrest. Cell cycle analysis data
revealed that treatment of leukemic cells with GC resulted in
a significant increase in apoptotic (sub G0) phase. These are
the features of a cell that is undergoing apoptotic cell death
(Hussain et al., 2006; Vignon et al., 2013). In subsequent our
data showed an increased Annexin/PI staining supporting that
GC-mediated cytotoxic effects are due to induction of apoptosis.
Caspases are hallmark of apoptosis that plays a critical role in
execution of apoptosis (MacKenzie and Clark, 2008; Hensley
et al., 2013).
Among caspase family caspase-3 has been shown to be a key
component of the apoptotic machinery (Nunez et al., 1998).
Caspase-3 is activated in apoptotic cells and cleaves several
cellular proteins, including PARP. The cleavage of PARP is
a hallmark of apoptosis by various antitumor agents (Duriez
and Shah, 1997). In our study, we show that GC treatment of
leukemic cells activates caspase-3 and cleaves PARP in a dose-
dependent manner. In addition, our data also found that GC
treatment phosphorylated H2AX, a marker for double-stranded
break which can lead DNA degradation and eventually apoptotic
cell death (Oben et al., 2017). Blocking of caspase activity by
pretreatment with a pan caspase inhibitor, zVAD-fmk prevented
GC-induced caspase-3 and PARP. These finding are strongly
suggesting that GC-mediated apoptotic cell death in leukemic
cells and the GC-induced apoptosis is caspase dependent.
The PI3k/AKT pathway plays a critical role in pro-survival
signaling that prevents apoptotic cell death in various cancer
cells (Uddin et al., 2006; Martelli et al., 2011; Brown and Banerji,
2017). High level of constitutive AKT activity has been linked
with shorter survival of patients in many cancers including
hematological malignancies (Uddin et al., 2006; Silva et al., 2008).
Our data showed that leukemic cells possess constitutive/basal
AKT activity (phosphorylated AKT) and treatment of with
these cells with GC suppresses phosphorylated AKT without
affecting the AKT proteins suggesting the role of AKT in
survival and proliferation of leukemic cells. Activated AKT
has been found to be involved in regulation of IAPs such as
XIAP, c-IAP1, and c-IAP2 (Gagnon et al., 2003; Seol, 2008;
Jo et al., 2017; Prabhu et al., 2018). Interestingly, XIAP has
been shown to be a physiologic substrate of AKT, that inhibit
programmed cell death and is directly involved in inhibition
of caspase-3 and caspase activity (Dan et al., 2004; Rada et al.,
2018). In this study we found that GC treatment of K562 and
U937 leukemic cells down regulated the expression of XIAP,
c-IAP1, and c-IAP2 in a dose-dependent manner. These findings
suggest that GC-mediated apoptosis occurs via inactivation
of AKT activity and downregulation of cIAPs in leukemic
cells.
Apoptosis or program cell death is an important event
that eliminates harmful and undesired cells to maintain the
balance between survival and cell death (Vasilikos et al., 2017).
There are two apoptotic pathways, the extrinsic or receptor-
mediated apoptotic that involved death receptors and the
intrinsic where mitochondrial signaling plays a major role. Most
of the anticancer agents induced apoptosis via mitochondrial
or intrinsic apoptotic pathway (Elmore, 2007; Lopez and Tait,
2015). Bcl-2 family members consist of pro-apoptotic molecule
like Bax, Bak, and anti-apoptotic members like Bcl-2, Bcl-
xL, etc. These members are known to play a significant and
crucial role in mitochondrial-mediated apoptotic pathway or
commonly known as intrinsic pathway (Wei et al., 2001;
Opferman and Kothari, 2018). In the present investigation, we
observed that GC treatment upregulated Bax expression and
diminished Bcl-2 expression in K562 and U937 cells. Elevated
Bax/Bcl2 ratio by GC resulted in a loss of mitochondrial
potential and release of cytochrome c from mitochondria to
cytosol in leukemic cells. It has been reported that complex
apoptosome are formed by cytochrome C, apoptosome protease
activating factor (APAF-1) and caspase-9 leading to cleavage of
caspase-9 and its activation. Then activated caspase activates
caspase-3 and intracellular PARP cleavage resulting in execution
apoptotic cell death (Jin and El-Deiry, 2005). Our study
is in concordance with these findings showing GC-induced
activation of caspase-9, caspase-3, and cleavage of PARP
suggesting that GC induced its apoptotic effects via intrinsic
pathway.
It is generally believed that increasing amounts of ROS and
resulting oxidative stress play an important role as a regulator
of apoptosis in various cancer cell types (Dayem et al., 2010).
Excessive ROS can cause cellular damage and lead to activation of
multiple death pathways, such as mitochondrial, death receptor,
and ER pathways of apoptosis (Redza-Dutordoir and Averill-
Bates, 2016). Many natural and synthetic agent/s have been
developed that induced apoptosis through ROS-mediated cell
damage. Consistent with this, our data generated by using various
experimental procedures showed a dose-dependent increase in
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ROS with subsequent decline in intracellular GSH content and
mitochondrial membrane potential. Depletion in levels of GSH
increased susceptibility to ROS resulting in DNA fragmentation
(Yeh et al., 2012). Furthermore, we also showed that GC-
induced proapoptotic effects is ROS dependent as pre-exposure
of leukemic cells with NAC, a ROS scavenger prevented GC-
induced loss of mitochondrial potential, GC-mediated caspase
activation, and GC-induced PARP activation.
CONCLUSION
Our finding demonstrates that GC-induced apoptosis occurs
via inactivation of AKT and through suppressive effects on
anti-apoptotic genes expression including XIAP, cIAPs, and Bcl-
xL. Furthermore, GC treatment downregulated Bcl-2 expression
with an increase in expression level of Bax resulting in collapse
of mitochondrial integrity with release of cytochrome c. Released
cytochrome c caused activation of pro-caspase-9, -3, and cleavage
of PARP resulting in activation of intrinsic apoptotic pathways
in leukemic cells. GC-induced its anticancer potential via ROS
production. Leukemic cells pre-treated with NAC prevented
GC-induced depletion of GSH as well as mitochondrial-caspase-
induced apoptosis. Taken together, our results show that GC
modulates the apoptotic response of human leukemic cells and
raises the possibility of its use as a novel therapeutic strategy for
hematological malignancies.
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